{ "dataset_name": "Ozempic U.S. Injection Price History and Supporting Benchmarks, 2017–2027", "version": "1.1", "date_published": "2026-08-03", "last_verified": "2026-08-03", "publisher": "Weight Loss Provider Guide Research", "canonical_url": "https://weightlossproviderguide.com/research/ozempic-price-history/", "geographic_scope": "United States, with clearly labeled Oregon-specific supporting series", "core_scope": "Published or reported Ozempic injection list-price/WAC observations. The 2017 and 2027 endpoints are announcements and are labeled separately.", "supporting_series": [ "HHS estimated non-Medicaid manufacturer net prices, 2018–2024", "Oregon commercial-carrier concession snapshot, 2023", "Oregon Medicaid fee-for-service AAAC, 2020–2024", "Manufacturer injection self-pay observations, 2025–2026", "Current injection and tablet package WAC snapshot, 2026", "CMS Medicare Maximum Fair Prices effective 2027", "BLS CPI-U inputs for a limited two-point adjustment", "Regulatory event documenting the Ozempic tablet name change", "Audit record documenting rejection of the $245 Bridge amount as an Ozempic benchmark" ], "methodology": { "annual_change_formula": "(current / prior - 1) * 100", "cumulative_change_baseline": "August 2018 historical benchmark of $729.40", "list_to_net_gap_formula": "list price - estimated net price", "list_to_net_gap_share_formula": "(list price - estimated net price) / list price * 100", "inflation_adjustment_formula": "historical price * comparison CPI / historical CPI", "compound_change_note": "The article's 4.4% compound figure treats 2018–2026 as eight year-labeled observation intervals. It is not a date-exact CAGR because the effective dates of the 2025 and 2026 increases were not established." }, "limitations": [ "WAC/list price is not patient out-of-pocket cost.", "The 2017 value is a planned price reported at approval.", "The exact August 2018 price is supported by contemporaneous reporting and later government histories.", "The effective dates of the 2025 and 2026 increases were not established.", "The 2027 WAC is announced and not yet effective as of the verification date.", "SSR Health net prices are estimates for non-Medicaid markets, not audited transactions.", "The calculated list-to-net gap is not a pure rebate rate.", "Oregon concession and AAAC data are state-specific.", "The Oregon AAAC and unit-WAC dollar levels should not be directly compared without confirmed unit definitions.", "CMS MFP values are Medicare-specific, not national WACs or guaranteed beneficiary copays.", "The $245 Medicare GLP-1 Bridge amount is not an Ozempic benchmark under CMS's current eligible-product list." ], "rows": [ { "record_id": "OPH-WAC-2017-12-05", "series_id": "core_injection_wac_history", "observation_date": "2017-12-05", "date_precision": "day", "year": 2017, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "676.00", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "Reported planned price", "status": "Announced planned price", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Reuters; U.S. Food and Drug Administration", "source_title": "FDA approval and contemporaneous planned-price report", "source_url": "https://www.reuters.com/article/business/healthcare-pharmaceuticals/fda-approves-novo-nordisk-diabetes-drug-ozempic-idUSKBN1DZ2O8/", "corroborating_source_url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209637s000ltr.pdf", "source_date": "2017-12-05", "last_verified": "2026-08-03", "notes": "Reported before commercial launch; not an observed transaction or verified in-market WAC." }, { "record_id": "OPH-WAC-2018-08-13", "series_id": "core_injection_wac_history", "observation_date": "2018-08-13", "date_precision": "day", "year": 2018, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "729.40", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "Reported list price per pen", "status": "Historical observation", "prior_value": "676.00", "change_value": "53.40", "change_pct": "7.8994", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "0.0000", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Fierce Pharma; HHS ASPE; Oregon PDAB", "source_title": "Contemporaneous U.S. rollout price and later government histories", "source_url": "https://www.fiercepharma.com/marketing/novo-has-a-big-pricing-decision-to-make-semaglutide-which-way-will-it-go", "corroborating_source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "source_date": "2018-08-13", "last_verified": "2026-08-03", "notes": "Fierce Pharma reported $729.40 per pen; Oregon later rounded the 2018 value to $729." }, { "record_id": "OPH-WAC-2019", "series_id": "core_injection_wac_history", "observation_date": "2019", "date_precision": "year", "year": 2019, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "772.43", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "729.40", "change_value": "43.03", "change_pct": "5.8994", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "5.8994", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Exact historical amount used in normalized annual series." }, { "record_id": "OPH-WAC-2020", "series_id": "core_injection_wac_history", "observation_date": "2020", "date_precision": "year", "year": 2020, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "811.05", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "772.43", "change_value": "38.62", "change_pct": "4.9998", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "11.1941", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Exact historical amount used in normalized annual series." }, { "record_id": "OPH-WAC-2021", "series_id": "core_injection_wac_history", "observation_date": "2021", "date_precision": "year", "year": 2021, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "851.60", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "811.05", "change_value": "40.55", "change_pct": "4.9997", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "16.7535", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Exact historical amount used in normalized annual series." }, { "record_id": "OPH-WAC-2022", "series_id": "core_injection_wac_history", "observation_date": "2022", "date_precision": "year", "year": 2022, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "892.06", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "851.60", "change_value": "40.46", "change_pct": "4.7511", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "22.3005", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Exact historical amount used in normalized annual series." }, { "record_id": "OPH-WAC-2023-12-31", "series_id": "core_injection_wac_history", "observation_date": "2023-12-31", "date_precision": "day", "year": 2023, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "935.77", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "892.06", "change_value": "43.71", "change_pct": "4.8999", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "28.2931", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Dated December 31, 2023 to avoid assigning the January 1, 2024 increase to 2023." }, { "record_id": "OPH-WAC-2024-01-01", "series_id": "core_injection_wac_history", "observation_date": "2024-01-01", "date_precision": "day", "year": 2024, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "968.52", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC/list price", "status": "Historical observation", "prior_value": "935.77", "change_value": "32.75", "change_pct": "3.4998", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "32.7831", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "2024 PDAB document package — Ozempic price history", "source_url": "https://dfr.oregon.gov/pdab/Documents/archive/20240221-PDAB-document-package.pdf", "corroborating_source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "source_date": "2024-02-21", "last_verified": "2026-08-03", "notes": "Official source reports a 3.5% increase effective January 1, 2024." }, { "record_id": "OPH-WAC-2025-11-06", "series_id": "core_injection_wac_history", "observation_date": "2025-11-06", "date_precision": "day", "year": 2025, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "997.58", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC", "status": "Manufacturer-attested amount", "prior_value": "968.52", "change_value": "29.06", "change_pct": "3.0005", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "36.7672", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk testimony to Massachusetts Health Policy Commission", "source_title": "2025 Cost Trends Hearing pre-filed testimony", "source_url": "https://masshpc.gov/sites/default/files/2025cth_pft_new_pharma_NNI_0.pdf", "corroborating_source_url": "", "source_date": "2025-11-06", "last_verified": "2026-08-03", "notes": "Amount verified; exact effective date of the increase was not established." }, { "record_id": "OPH-WAC-2026-05", "series_id": "core_injection_wac_history", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "1027.51", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "997.58", "change_value": "29.93", "change_pct": "3.0003", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "40.8706", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Current page lists the same WAC for each displayed injection pen package; exact increase date not established." }, { "record_id": "OPH-WAC-2027-01-01", "series_id": "core_injection_wac_history", "observation_date": "2027-01-01", "date_precision": "day", "year": 2027, "geography": "United States", "product_scope": "Ozempic injection", "measure_name": "Published list-price/WAC observation", "value_numeric": "675.00", "unit": "USD per one-pen / approximately 30-day benchmark", "currency": "USD", "price_type": "WAC", "status": "Announced future amount", "prior_value": "1027.51", "change_value": "-352.51", "change_pct": "-34.3072", "cumulative_baseline": "August 2018 = $729.40", "cumulative_change_pct": "-7.4582", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk announces significant reduction in U.S. list price", "source_url": "https://www.prnewswire.com/news-releases/novo-nordisk-announces-significant-reduction-in-us-list-price-for-wegovy-ozempic-and-rybelsus-semaglutide-medicines-building-on-continued-efforts-to-expand-access-302695705.html", "corroborating_source_url": "", "source_date": "2026-02-24", "last_verified": "2026-08-03", "notes": "Scheduled for January 1, 2027; not yet effective as of the verification date." }, { "record_id": "OPH-NET-2018", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2018", "date_precision": "year", "year": 2018, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "531.08", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "729.40", "list_to_net_gap": "198.32", "list_to_net_gap_pct": "27.1895", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2019", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2019", "date_precision": "year", "year": 2019, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "498.83", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "772.43", "list_to_net_gap": "273.60", "list_to_net_gap_pct": "35.4207", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2020", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2020", "date_precision": "year", "year": 2020, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "460.75", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "811.05", "list_to_net_gap": "350.30", "list_to_net_gap_pct": "43.1909", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2021", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2021", "date_precision": "year", "year": 2021, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "430.92", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "851.60", "list_to_net_gap": "420.68", "list_to_net_gap_pct": "49.3988", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2022", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2022", "date_precision": "year", "year": 2022, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "369.75", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "892.06", "list_to_net_gap": "522.31", "list_to_net_gap_pct": "58.5510", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2023", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "319.67", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "935.77", "list_to_net_gap": "616.10", "list_to_net_gap_pct": "65.8388", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-NET-2024", "series_id": "estimated_non_medicaid_manufacturer_net_price", "observation_date": "2024", "date_precision": "year", "year": 2024, "geography": "United States; non-Medicaid markets", "product_scope": "Ozempic", "measure_name": "Estimated non-Medicaid manufacturer net price", "value_numeric": "290.08", "unit": "USD per normalized monthly supply", "currency": "USD", "price_type": "Estimated manufacturer net price", "status": "HHS-published estimate", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "968.52", "list_to_net_gap": "678.44", "list_to_net_gap_pct": "70.0491", "source_organization": "HHS ASPE; SSR Health", "source_title": "Medicare Coverage of Anti-Obesity Medications, Issue Brief HP-2024-25", "source_url": "https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf", "corroborating_source_url": "", "source_date": "2024-11-26", "last_verified": "2026-08-03", "notes": "Four-quarter rolling SSR Health estimate for non-Medicaid markets; not an audited transaction price." }, { "record_id": "OPH-OR-CONCESSION-2023-ENROLLEES", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "enrollees", "value_numeric": "16254", "unit": "people", "currency": "", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-CLAIMS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "claims", "value_numeric": "48107", "unit": "claims", "currency": "", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-CLAIMS_WITH_PRICE_CONCESSION", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "claims_with_price_concession", "value_numeric": "41258", "unit": "claims", "currency": "", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-CLAIMS_WITH_CONCESSION_PCT", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "claims_with_concession_pct", "value_numeric": "85.8", "unit": "percent", "currency": "", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-COST_BEFORE_CONCESSIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "cost_before_concessions", "value_numeric": "51483857", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-MANUFACTURER_PRICE_CONCESSIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "manufacturer_price_concessions", "value_numeric": "21165105", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-PBM_PRICE_CONCESSIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "pbm_price_concessions", "value_numeric": "3269305", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-OTHER_PRICE_REDUCTIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "other_price_reductions", "value_numeric": "3408", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-TOTAL_REPORTED_CONCESSIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "total_reported_concessions", "value_numeric": "24437818", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-COST_AFTER_CONCESSIONS", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "cost_after_concessions", "value_numeric": "27046039", "unit": "USD", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-GROSS_PAYER_SPEND_PER_ENROLLEE", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "gross_payer_spend_per_enrollee", "value_numeric": "3167", "unit": "USD per enrollee", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-AFTER_CONCESSION_PAYER_SPEND_PER_ENROLLEE", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "after_concession_payer_spend_per_enrollee", "value_numeric": "1664", "unit": "USD per enrollee", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-GROSS_SPEND_PER_CLAIM", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "gross_spend_per_claim", "value_numeric": "1070", "unit": "USD per claim", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-AFTER_CONCESSION_SPEND_PER_CLAIM", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "after_concession_spend_per_claim", "value_numeric": "562", "unit": "USD per claim", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-OR-CONCESSION-2023-PRICE_CONCESSION_PER_CLAIM", "series_id": "oregon_commercial_carrier_concessions_2023", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon commercial market; carrier-submitted data", "product_scope": "Ozempic", "measure_name": "price_concession_per_claim", "value_numeric": "508", "unit": "USD per claim", "currency": "USD", "price_type": "Carrier-reported gross/after-concession metric", "status": "Official state affordability-review metric", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board", "source_title": "Ozempic affordability review, Tables 7 and 8", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "State-specific carrier submission; not a national manufacturer net price." }, { "record_id": "OPH-AAAC-ANNUAL-2020", "series_id": "oregon_medicaid_aaac_annual_average", "observation_date": "2020", "date_precision": "year", "year": 2020, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Annual average Actual Average Acquisition Cost", "value_numeric": "389.00", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review, Table 6", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Annual average rounded to the dollar in the official table. Do not compare its dollar level directly with package WAC without confirmed unit definitions." }, { "record_id": "OPH-AAAC-ANNUAL-2021", "series_id": "oregon_medicaid_aaac_annual_average", "observation_date": "2021", "date_precision": "year", "year": 2021, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Annual average Actual Average Acquisition Cost", "value_numeric": "389.00", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review, Table 6", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Annual average rounded to the dollar in the official table. Do not compare its dollar level directly with package WAC without confirmed unit definitions." }, { "record_id": "OPH-AAAC-ANNUAL-2022", "series_id": "oregon_medicaid_aaac_annual_average", "observation_date": "2022", "date_precision": "year", "year": 2022, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Annual average Actual Average Acquisition Cost", "value_numeric": "374.00", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review, Table 6", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Annual average rounded to the dollar in the official table. Do not compare its dollar level directly with package WAC without confirmed unit definitions." }, { "record_id": "OPH-AAAC-ANNUAL-2023", "series_id": "oregon_medicaid_aaac_annual_average", "observation_date": "2023", "date_precision": "year", "year": 2023, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Annual average Actual Average Acquisition Cost", "value_numeric": "366.00", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review, Table 6", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Annual average rounded to the dollar in the official table. Do not compare its dollar level directly with package WAC without confirmed unit definitions." }, { "record_id": "OPH-AAAC-ANNUAL-2024", "series_id": "oregon_medicaid_aaac_annual_average", "observation_date": "2024", "date_precision": "year", "year": 2024, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Annual average Actual Average Acquisition Cost", "value_numeric": "382.00", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review, Table 6", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Annual average rounded to the dollar in the official table. Do not compare its dollar level directly with package WAC without confirmed unit definitions." }, { "record_id": "OPH-AAAC-Q1-2020", "series_id": "oregon_medicaid_aaac_quarter_endpoints", "observation_date": "2020-Q1", "date_precision": "quarter", "year": 2020, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Actual Average Acquisition Cost endpoint", "value_numeric": "386.65", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Quarter-one endpoint stated in the official narrative." }, { "record_id": "OPH-AAAC-Q4-2024", "series_id": "oregon_medicaid_aaac_quarter_endpoints", "observation_date": "2024-Q4", "date_precision": "quarter", "year": 2024, "geography": "Oregon Medicaid fee-for-service", "product_scope": "Ozempic", "measure_name": "Actual Average Acquisition Cost endpoint", "value_numeric": "387.93", "unit": "USD per reported unit", "currency": "USD", "price_type": "Oregon AAAC", "status": "Official state survey-based benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Oregon Prescription Drug Affordability Board; Oregon Health Authority", "source_title": "Ozempic affordability review", "source_url": "https://dfr.oregon.gov/pdab/Documents/Ozempic.pdf", "corroborating_source_url": "", "source_date": "2025-12-05", "last_verified": "2026-08-03", "notes": "Quarter-four endpoint stated in the official narrative." }, { "record_id": "OPH-SELF-2025-08-18", "series_id": "manufacturer_injection_self_pay", "observation_date": "2025-08-18", "date_precision": "day", "year": 2025, "geography": "United States", "product_scope": "Ozempic injection; eligible self-paying patients", "measure_name": "Manufacturer self-pay amount", "value_numeric": "499.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Initial national manufacturer offer located in this review", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.prnewswire.com/news-releases/novo-nordisk-lowers-cost-of-ozempic-to-499-per-month-for-self-paying-patients-in-support-of-patient-access-to-authentic-fda-approved-semaglutide-medicines-302532208.html", "corroborating_source_url": "", "source_date": "2025-08-18", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2025-11-17-INTRO", "series_id": "manufacturer_injection_self_pay", "observation_date": "2025-11-17", "date_precision": "day", "year": 2025, "geography": "United States", "product_scope": "First two monthly fills at injection 0.25 mg or 0.5 mg for qualifying new patients", "measure_name": "Manufacturer self-pay amount", "value_numeric": "199.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Limited introductory offer", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.prnewswire.com/news-releases/novo-nordisk-launches-introductory-self-pay-offer-for-wegovy-and-ozempic-for-199-per-month-302617100.html", "corroborating_source_url": "", "source_date": "2025-11-17", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2025-11-17-LOWER", "series_id": "manufacturer_injection_self_pay", "observation_date": "2025-11-17", "date_precision": "day", "year": 2025, "geography": "United States", "product_scope": "Injection 0.25 mg, 0.5 mg, or 1 mg", "measure_name": "Manufacturer self-pay amount", "value_numeric": "349.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Standard self-pay amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.prnewswire.com/news-releases/novo-nordisk-launches-introductory-self-pay-offer-for-wegovy-and-ozempic-for-199-per-month-302617100.html", "corroborating_source_url": "", "source_date": "2025-11-17", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2025-11-17-2MG", "series_id": "manufacturer_injection_self_pay", "observation_date": "2025-11-17", "date_precision": "day", "year": 2025, "geography": "United States", "product_scope": "Injection 2 mg", "measure_name": "Manufacturer self-pay amount", "value_numeric": "499.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Standard self-pay amount remained $499", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.prnewswire.com/news-releases/novo-nordisk-launches-introductory-self-pay-offer-for-wegovy-and-ozempic-for-199-per-month-302617100.html", "corroborating_source_url": "", "source_date": "2025-11-17", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2026-08-03-INTRO", "series_id": "manufacturer_injection_self_pay", "observation_date": "2026-08-03", "date_precision": "day", "year": 2026, "geography": "United States", "product_scope": "First two qualifying monthly fills at injection 0.25 mg or 0.5 mg", "measure_name": "Manufacturer self-pay amount", "value_numeric": "199.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Current introductory offer stated through December 31, 2026", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.novocare.com/diabetes/products/ozempic/savings-offer.html", "corroborating_source_url": "", "source_date": "2026-08-03", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2026-08-03-LOWER", "series_id": "manufacturer_injection_self_pay", "observation_date": "2026-08-03", "date_precision": "day", "year": 2026, "geography": "United States", "product_scope": "Injection 0.25 mg, 0.5 mg, or 1 mg after introductory fills", "measure_name": "Manufacturer self-pay amount", "value_numeric": "349.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Current standard self-pay amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.novocare.com/diabetes/products/ozempic/savings-offer.html", "corroborating_source_url": "", "source_date": "2026-08-03", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-SELF-2026-08-03-2MG", "series_id": "manufacturer_injection_self_pay", "observation_date": "2026-08-03", "date_precision": "day", "year": 2026, "geography": "United States", "product_scope": "Injection 2 mg", "measure_name": "Manufacturer self-pay amount", "value_numeric": "499.00", "unit": "USD per monthly fill", "currency": "USD", "price_type": "Manufacturer self-pay", "status": "Current standard self-pay amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Novo Nordisk self-pay announcement or current NovoCare terms", "source_url": "https://www.novocare.com/diabetes/products/ozempic/savings-offer.html", "corroborating_source_url": "", "source_date": "2026-08-03", "last_verified": "2026-08-03", "notes": "Program price; dose, channel, duration, and eligibility terms apply. Current page permits government-insured individuals to use self-pay outside insurance; payments do not count toward insurance cost sharing." }, { "record_id": "OPH-CURRENT-INJ-025-05", "series_id": "current_injection_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic injection 0.25 mg or 0.5 mg dose, 3 mL pen, one-pen package", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-CURRENT-INJ-1", "series_id": "current_injection_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic injection 1 mg dose, 3 mL pen, one-pen package", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-CURRENT-INJ-2", "series_id": "current_injection_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic injection 2 mg dose, 3 mL pen, one-pen package", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-CURRENT-TAB-15", "series_id": "current_tablet_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic tablets 1.5 mg, bottle of 30", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-CURRENT-TAB-4", "series_id": "current_tablet_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic tablets 4 mg, bottle of 30", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-CURRENT-TAB-9", "series_id": "current_tablet_package_wac", "observation_date": "2026-05", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "Ozempic tablets 9 mg, bottle of 30", "measure_name": "Current package WAC", "value_numeric": "1027.51", "unit": "USD per package", "currency": "USD", "price_type": "WAC", "status": "Current manufacturer-published amount", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Novo Nordisk", "source_title": "Ozempic Pricing", "source_url": "https://www.novopricing.com/ozempic.html", "corroborating_source_url": "", "source_date": "2026-05", "last_verified": "2026-08-03", "notes": "Package-specific row from the manufacturer price-transparency page." }, { "record_id": "OPH-MFP-2027-30DAY", "series_id": "medicare_maximum_fair_price_2027", "observation_date": "2027-01-01", "date_precision": "day", "year": 2027, "geography": "United States; Medicare", "product_scope": "Selected-drug grouping: Ozempic; Rybelsus; Wegovy", "measure_name": "Rounded 30-day Maximum Fair Price", "value_numeric": "274.00", "unit": "USD", "currency": "USD", "price_type": "Medicare Maximum Fair Price", "status": "Negotiated price effective January 1, 2027", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Centers for Medicare & Medicaid Services", "source_title": "Negotiated Prices for Initial Price Applicability Year 2027", "source_url": "https://www.cms.gov/files/document/fact-sheet-negotiated-prices-ipay-2027.pdf", "corroborating_source_url": "", "source_date": "2025-11-25", "last_verified": "2026-08-03", "notes": "CMS reports a rounded 2024 WAC basis of $959 and a 71% discount. Not a national WAC or guaranteed beneficiary copay." }, { "record_id": "OPH-MFP-2027-PACKAGE", "series_id": "medicare_maximum_fair_price_2027", "observation_date": "2027-01-01", "date_precision": "day", "year": 2027, "geography": "United States; Medicare", "product_scope": "Ozempic NDC 00169-4130-13, one 4 mg/3 mL pen", "measure_name": "Package-specific Maximum Fair Price", "value_numeric": "276.78", "unit": "USD", "currency": "USD", "price_type": "Medicare Maximum Fair Price", "status": "Negotiated price effective January 1, 2027", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Centers for Medicare & Medicaid Services", "source_title": "Negotiated Prices for Initial Price Applicability Year 2027", "source_url": "https://www.cms.gov/files/document/fact-sheet-negotiated-prices-ipay-2027.pdf", "corroborating_source_url": "", "source_date": "2025-11-25", "last_verified": "2026-08-03", "notes": "Package-specific example in the CMS fact sheet. Not a national WAC or guaranteed beneficiary copay." }, { "record_id": "OPH-CPI-2018-08", "series_id": "cpi_u_inputs", "observation_date": "2018-08", "date_precision": "month", "year": 2018, "geography": "United States", "product_scope": "All items", "measure_name": "CPI-U, not seasonally adjusted", "value_numeric": "252.146", "unit": "index, 1982-84=100", "currency": "", "price_type": "CPI-U", "status": "Official BLS historical value", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "U.S. Bureau of Labor Statistics", "source_title": "Historical Consumer Price Index for All Urban Consumers", "source_url": "https://www.bls.gov/regions/mid-atlantic/data/consumerpriceindexhistorical_us_table.htm", "corroborating_source_url": "", "source_date": "2018-08", "last_verified": "2026-08-03", "notes": "Input for the limited two-point inflation adjustment." }, { "record_id": "OPH-CPI-2026-06", "series_id": "cpi_u_inputs", "observation_date": "2026-06", "date_precision": "month", "year": 2026, "geography": "United States", "product_scope": "All items", "measure_name": "CPI-U, not seasonally adjusted", "value_numeric": "333.952", "unit": "index, 1982-84=100", "currency": "", "price_type": "CPI-U", "status": "Official BLS historical value", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "U.S. Bureau of Labor Statistics", "source_title": "Historical Consumer Price Index for All Urban Consumers", "source_url": "https://www.bls.gov/regions/mid-atlantic/data/consumerpriceindexhistorical_us_table.htm", "corroborating_source_url": "", "source_date": "2026-06", "last_verified": "2026-08-03", "notes": "Input for the limited two-point inflation adjustment." }, { "record_id": "OPH-EVENT-2026-01-30-TABLETS", "series_id": "product_scope_events", "observation_date": "2026-01-30", "date_precision": "day", "year": 2026, "geography": "United States", "product_scope": "Ozempic tablets; Rybelsus formulation R2", "measure_name": "FDA-approved product-name change", "value_numeric": "", "unit": "", "currency": "", "price_type": "Regulatory event", "status": "FDA approved", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "U.S. Food and Drug Administration", "source_title": "NDA 213051/S-030 supplement approval", "source_url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/213051Orig1s030ltr.pdf", "corroborating_source_url": "", "source_date": "2026-01-30", "last_verified": "2026-08-03", "notes": "FDA approved changing the product name from Rybelsus formulation R2 to Ozempic tablets." }, { "record_id": "OPH-AUDIT-REJECT-245-BRIDGE", "series_id": "audit_rejected_claims", "observation_date": "2026-08-03", "date_precision": "day", "year": 2026, "geography": "United States; Medicare", "product_scope": "Medicare GLP-1 Bridge", "measure_name": "Rejected claim: $245 is an Ozempic Bridge price", "value_numeric": "245.00", "unit": "USD per monthly supply", "currency": "USD", "price_type": "Bridge manufacturer net price for eligible products", "status": "Rejected as an Ozempic benchmark", "prior_value": "", "change_value": "", "change_pct": "", "cumulative_baseline": "", "cumulative_change_pct": "", "paired_list_price": "", "list_to_net_gap": "", "list_to_net_gap_pct": "", "source_organization": "Centers for Medicare & Medicaid Services", "source_title": "Medicare GLP-1 Bridge information for Part D plans", "source_url": "https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-part-d-plans", "corroborating_source_url": "", "source_date": "2026-08-03", "last_verified": "2026-08-03", "notes": "The $245 Bridge net price applies to eligible products. CMS currently lists Foundayo, Wegovy, and Zepbound KwikPen; Ozempic is not listed." } ] }